Financial Performance - The company's operating revenue for the first half of 2022 was ¥38.36 billion, a decrease of 3.90% compared to ¥39.91 billion in the same period last year[22]. - The net profit attributable to shareholders was ¥62.86 million, down 52.41% from ¥132.09 million year-on-year[22]. - The net profit after deducting non-recurring gains and losses was -¥46.15 million, a decline of 135.17% compared to ¥131.20 million in the previous year[22]. - The net cash flow from operating activities was -¥1.62 billion, a decrease of 442.93% from ¥471.23 million in the same period last year[22]. - The company's basic and diluted earnings per share were both ¥0.12, a decrease of 52.00% from ¥0.25 in the same period last year[22]. - The weighted average return on net assets was 2.15%, down 2.74% from 4.89% in the previous year[22]. - The total revenue for the reporting period was ¥38,356,068,178.09, a decrease of 3.90% compared to ¥39,914,455,589.17 in the same period last year[51]. - The cost of goods sold was ¥38,082,876,704.66, down 3.01% from ¥39,266,005,722.83 year-over-year[51]. - The net profit for the same period was CNY 69.376 million, representing a significant decline of 67.67% year-on-year[79]. - The total comprehensive income for the first half of 2022 was CNY 98.14 million, compared to CNY 162.68 million in the same period of 2021, reflecting a decline of approximately 39.5%[163]. Assets and Liabilities - The total assets at the end of the reporting period were ¥8.46 billion, an increase of 10.85% from ¥7.63 billion at the end of the previous year[22]. - The net assets attributable to shareholders at the end of the reporting period were ¥2.94 billion, up 1.96% from ¥2.88 billion at the end of the previous year[22]. - The company's total assets increased to CNY 8.46 billion as of June 30, 2022, compared to CNY 7.63 billion at the beginning of the year, reflecting a growth of 10.8%[155]. - Total liabilities rose to CNY 5.25 billion, up from CNY 4.53 billion at the start of the year, marking an increase of 15.9%[155]. - The company's equity attributable to shareholders reached CNY 2.94 billion, compared to CNY 2.88 billion at the beginning of the year, representing a growth of 2.9%[155]. Cash Flow - The company's cash and cash equivalents decreased by 157.73% to -¥634,909,368.89, primarily due to the negative cash flow from operating activities[51]. - The net cash flow from operating activities was negative at -¥1,616,001,881.29, a decline of 442.93% compared to ¥471,232,899.04 in the previous year[51]. - The net cash flow from investment activities was 350,780,371.41 CNY, a decrease of 26.1% compared to 474,889,049.70 CNY in the previous period[169]. - The net cash flow from financing activities increased significantly to 575,454,940.14 CNY, compared to 151,468,636.76 CNY in the same period last year, marking an increase of 279.5%[169]. - The cash flow from operating activities was primarily driven by an increase in cash received from other operating activities, which rose to 847,083,182.82 CNY from 566,486,226.33 CNY, an increase of 49.5%[170]. Business Strategy and Operations - The company is focusing on the integration of trade, oil, and ecological agriculture, aiming for a high-tech enterprise transformation[34]. - The company has established over 30 subsidiaries and has set up business institutions in multiple countries and regions[32]. - The company is enhancing its oil and fat business by expanding its upstream resource acquisition and improving processing capabilities[39]. - The company aims to build a global vertical industry chain integrating raw materials, storage, refining, and end products, striving to become a leader in the oil industry[43]. - The company is focusing on ecological agriculture, providing green crop management solutions to professional growers, and emphasizing research and innovation[44]. Research and Development - The company has rapidly built a biological pesticide production system and is developing a range of innovative biological pesticide products[45]. - The company plans to enhance its ecological agriculture product offerings through collaborations with research institutions and continuous innovation[47]. - New product development initiatives are underway, with an investment of 12,870 million allocated for R&D in 2022, compared to 6,000 million in 2021, marking a 114.5% increase[122]. - Research and development expenses for the first half of 2022 were CNY 1.92 million, with no prior year data available for comparison[162]. Risk Management - The company emphasizes risk management and has implemented measures to mitigate foreign exchange risks[36]. - The company has established strict risk management processes for derivative investments, including stop-loss mechanisms and compliance with legal regulations[78]. - The company faced market risks associated with price fluctuations in derivative trading, which could lead to trading losses[73]. - Liquidity risks were identified due to potential large investment amounts in futures trading, which could result in forced liquidation if margin calls are not met[73]. - Credit risks were highlighted, particularly from potential defaults by clients during commodity price fluctuations[73]. Environmental Compliance - Yuan Da Oil (Dongguan) reported a wastewater discharge of 3.237 tons/year, with a COD concentration of 55.51 mg/L, which is below the standard limit of 90 mg/L[91]. - The company operates a wastewater treatment facility with a capacity of 360 tons/day, which is functioning normally[92]. - The company has a VOCs emission of 3.36 tons/year, with a concentration of 15.4 mg/m³, compliant with the emission standard[91]. - Both companies maintain a commitment to environmental protection and compliance with local regulations, ensuring sustainable operations[94]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[96]. Shareholder and Equity Information - The company reported a total of 209,522,100 shares held by its largest shareholder, China Yuanda Group, representing 41.17% of total shares[139]. - The second-largest shareholder, Lianyungang Jinkong Capital Management Co., Ltd., holds 82,072,000 shares, accounting for 16.13%[139]. - The company has not undergone any changes in its controlling shareholder during the reporting period[142]. - The company does not plan to distribute cash dividends or issue bonus shares for the half-year period[87]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[101]. Future Outlook - Future guidance estimates a revenue growth of 20% for the full year 2022, aiming for a total of 1.2 billion yuan[175]. - The company plans to enhance production process upgrades and product innovation to capture market opportunities amid increasing competition[81]. - The company is considering potential acquisitions to bolster its market position, with a budget of 13,475 million earmarked for strategic acquisitions in 2022[122]. - The company aims to enhance its technological capabilities, focusing on sustainable energy solutions, with a projected budget of 5,000 million for technology upgrades in 2022[122].

Financial Performance - The company's operating revenue for Q1 2022 was ¥17,076,716,532.60, a decrease of 4.44% compared to ¥17,870,174,057.49 in the same period last year[3] - Net profit attributable to shareholders was ¥11,149,720.14, down 81.15% from ¥59,136,325.01 year-on-year[3] - Basic and diluted earnings per share were both ¥0.02, down 83.33% from ¥0.12 in the same period last year[3] - Net profit for the current period is ¥21,081,266.64, a decline of 75.32% compared to ¥85,520,902.55 in the previous period[26] - The total profit for the current period is ¥42,377,029.34, a decrease of 59.93% from ¥105,741,516.00 in the previous period[26] - Other comprehensive income after tax for the current period is -¥8,251,074.04, contrasting with a gain of ¥180,619.84 in the previous period[26] Cash Flow - The net cash flow from operating activities was -¥1,191,402,355.34, representing a decline of 446.84% compared to -¥217,869,955.55 in the previous year[3] - The company reported a net cash outflow from operating activities of ¥1,191,402,355.34, compared to an outflow of ¥217,869,955.55 in the previous period[28] - The net cash flow from investing activities surged by 393.90% to ¥606,518,752.47, primarily due to cash received from redeeming financial products[8] - The company achieved an investment activity net cash inflow of ¥606,518,752.47, compared to ¥122,802,991.70 in the previous period[29] Assets and Liabilities - Total assets increased by 11.31% to ¥8,491,495,668.20 from ¥7,628,880,311.03 at the end of the previous year[3] - The company's total liabilities increased to CNY 5,379,197,029.33 from CNY 4,529,411,864.76, representing a rise of about 18.7%[23] - Cash and cash equivalents decreased to CNY 3,015,439,025.36 from CNY 3,132,935,277.32, a decline of about 3.8%[21] - Total current assets reached CNY 7,463,608,184.35, up from CNY 6,605,743,041.89, showing an increase of approximately 13.0%[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,794[10] - China Yuanda Group holds 41.17% of shares, totaling 209,522,100 shares[10] - The company repurchased shares as part of its strategy to enhance shareholder value, with announcements made on April 7, 2022[19] Business Strategy and Expansion - The company has over 30 subsidiaries and is expanding its business in multiple countries and regions[12] - The company has established strategic partnerships with several Fortune 500 companies in the bulk commodity trading sector[13] - In April 2022, the company acquired 80% of Guangdong Hongxin Food Co., Ltd., entering the specialty oil sector[14] - The company is transitioning its business model from single trade profit to integrated supply chain services[13] - The company aims to contribute to national food security and green development through its operations[12] - The acquisition of Shaanxi Maikelo Biotechnology Co., Ltd. is currently under audit and evaluation, with uncertainty regarding its implementation[16] Operational Metrics - The company experienced a 50.30% reduction in selling expenses, totaling ¥54,922,876.93, attributed to lower employee compensation[8] - The weighted average return on equity decreased to 0.39% from 2.22% in the previous year[3] - The company reported a significant increase in accounts receivable, which rose by 101.79% to ¥1,226,554,136.84 due to higher shipment volumes[7] - Inventory levels increased by 58.99% to ¥1,355,174,429.56, driven by expectations of rising product prices[7] - Short-term borrowings surged to CNY 811,956,391.57 from CNY 390,671,110.81, an increase of approximately 108.5%[22]

Financial Performance - The company's operating revenue for 2021 was ¥81,561,908,376.25, representing a 38.14% increase compared to ¥59,041,455,357.74 in 2020[18]. - The net profit attributable to shareholders for 2021 was ¥222,141,582.30, a significant turnaround from a loss of ¥113,193,841.51 in 2020, marking a 296.25% increase[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥106,101,976.91, up 129.60% from ¥46,212,410.38 in 2020[18]. - The net cash flow from operating activities was ¥767,587,134.79, a 325.56% increase from a negative cash flow of ¥340,301,495.45 in 2020[18]. - The basic earnings per share for 2021 was ¥0.43, compared to a loss of ¥0.21 per share in 2020, reflecting a 304.76% improvement[18]. - The total assets at the end of 2021 were ¥7,628,880,311.03, a 15.34% increase from ¥6,614,086,516.44 at the end of 2020[18]. - The net assets attributable to shareholders at the end of 2021 were ¥2,880,831,939.26, up 9.12% from ¥2,640,159,069.96 at the end of 2020[18]. - The weighted average return on equity for 2021 was 8.05%, a recovery from -4.17% in 2020, indicating a 12.22% improvement[18]. Revenue Breakdown - The company's total revenue for Q1, Q2, Q3, and Q4 was approximately ¥17.87 billion, ¥22.04 billion, ¥20.16 billion, and ¥21.48 billion respectively, showing a strong performance in Q2[22]. - The revenue from commodity trading accounted for 99.82% of total operating revenue, amounting to ¥81.41 billion, which is a 38.14% increase from the previous year[60]. - Domestic sales contributed ¥70.70 billion, accounting for 86.68% of total revenue, with a year-on-year growth of 38.48%[60]. Strategic Initiatives - The company aims to integrate vertically across the palm oil supply chain, enhancing its competitive edge in the market[32]. - The company is focusing on the high-end edible oil market, which is expected to grow due to rising consumer health awareness and income levels[31]. - The company has established over 30 subsidiaries and is actively expanding its business in multiple countries and regions, emphasizing the integration of trade and high-tech agriculture[36]. - The company plans to acquire Guangdong Hongxin to enter the specialty oils market, further deepening its full industry chain layout[38]. - The company has initiated the industrialization process of ecological agriculture, collaborating with the Chinese Academy of Agricultural Sciences to establish a research and development center[40]. Environmental and Social Responsibility - The company is committed to environmental, social, and governance performance, aligning its operations with national goals for carbon neutrality and ecological protection[36]. - The company aims to achieve zero emissions in industrial wastewater and waste during the production of its biological pesticides, aligning with environmental sustainability goals[45]. - The company emphasizes social responsibility, providing equal employment opportunities and adhering to labor laws[170]. - The company continues to promote the "Yuan Da Anxin Village" social welfare project, donating educational materials to schools in need[170]. Risk Management - The company has developed a comprehensive risk management system to ensure effective control of risks while pursuing profit[42]. - The company has identified several key risks, including market risk and liquidity risk, which it is actively managing[92]. - The company has established a risk management system to monitor market risks associated with its hedging business model, ensuring effective execution of its strategies[110]. - The company is implementing strategies to mitigate foreign exchange risks, utilizing appropriate hedging tools to minimize the impact of currency fluctuations on its operating performance[111]. Corporate Governance - The company adheres to regulatory requirements for corporate governance, ensuring compliance with laws and maintaining the interests of all shareholders[114]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring no conflicts of interest[116]. - The company is committed to a production and operational model that is independent from its controlling shareholders, ensuring no competitive conflicts arise[119]. - The board of directors has been proactive in addressing potential risks related to goodwill impairment and management team integration during acquisitions[144]. Subsidiary Developments - The company acquired 100% equity of Liaoning Weike Biological Engineering Co., Ltd. and 85.1166% equity of Fujian Kaili Biological Products Co., Ltd. in 2021[138]. - The newly established subsidiary, Yuan Da Energy Chemical (Singapore) Co., Ltd., reported revenue of CNY 82,755,503.12 but incurred a net loss of CNY 6,128,397.30 during the reporting period[190]. - The company also established Yuan Da Rubber (Singapore) Co., Ltd., which generated revenue of CNY 522,644,021.01 with a net loss of CNY 898,312.71[190]. Future Outlook - The company plans to expand its market presence, focusing on new product development and technological advancements[92]. - The company aims to transition from a B2B model to a B2C model by developing small packaged palm oil products and exploring high-value specialty oils[107]. - The company is likely to pursue further strategic initiatives, including potential mergers and acquisitions, to bolster its market position[128].

Financial Performance - The company's operating revenue for Q3 2021 was ¥20,164,110,380.86, representing a 22.58% increase year-over-year[3]. - Net profit attributable to shareholders for the same period was ¥81,421,377.39, a significant increase of 73.93% compared to the previous year[3]. - The basic earnings per share for Q3 2021 was ¥0.16, reflecting an 85.61% increase year-over-year[3]. - In the first three quarters of 2021, the company achieved operating revenue of CNY 60.08 billion, an increase of 50.84% compared to the same period last year[13]. - The net profit attributable to shareholders of the listed company was CNY 2.14 billion, turning from a loss of CNY 0.52 billion in the same period last year, representing a growth of 508.64%[13]. - Total operating revenue for the current period reached ¥60,078,565,970.03, a significant increase of 50.8% compared to ¥39,828,721,919.73 in the previous period[25]. - Net profit for the current period was ¥261,956,084.21, a turnaround from a net loss of ¥482,786.39 in the previous period[26]. - The profit attributable to the parent company's shareholders was ¥213,511,259.22, compared to a loss of ¥52,248,872.42 in the same period last year[26]. - Earnings per share (basic and diluted) improved to ¥0.41 from a loss of ¥0.10 in the previous period[27]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥8,521,954,349.32, marking a 28.85% increase from the end of the previous year[3]. - The total assets of the company as of September 30, 2021, were CNY 85.22 billion, an increase of 28.85% from the end of the previous year[13]. - The company’s total current assets increased to approximately CNY 7.53 billion as of September 30, 2021, compared to CNY 6.07 billion at the end of 2020, reflecting a growth of about 24.1%[21]. - The company’s total liabilities increased to approximately CNY 4.98 billion as of September 30, 2021, compared to CNY 3.65 billion at the end of 2020, indicating a growth of about 36.5%[22]. - Total liabilities increased to ¥5,385,132,008.05 from ¥3,796,158,878.80, indicating a growth of 42%[26]. - Total liabilities amounted to CNY 3,796,158,878.80, with current liabilities at CNY 3,647,163,716.33[35]. - Non-current liabilities totaled CNY 148,995,162.47, including lease liabilities of CNY 80,999,995.79[35]. Cash Flow - The company reported a cash flow from operating activities of ¥307,949,261.94, which is a 167.68% increase year-to-date[3]. - The company reported a cash flow from operating activities of CNY 307.95 million, a turnaround from a negative cash flow of CNY 455.02 million in the same period last year, representing a growth of 167.68%[12]. - Cash generated from operating activities was ¥66,108,607,914.03, an increase from ¥44,767,061,249.95 in the prior period[29]. - The net cash flow from operating activities was CNY 307,949,261.94, a significant improvement compared to a negative cash flow of CNY -455,019,204.43 in the same period last year[30]. - The total cash inflow from investment activities reached CNY 8,663,411,829.92, up from CNY 6,026,619,609.68 year-over-year[30]. - The net cash flow from financing activities was CNY 360,188,841.29, compared to CNY 129,678,510.36 in the previous year, indicating a positive trend in financing[31]. - The total cash and cash equivalents at the end of the period amounted to CNY 2,409,527,305.21, an increase from CNY 1,880,779,075.19 at the end of the previous year[31]. - The company reported a total investment cash outflow of CNY 8,025,084,423.01, compared to CNY 5,532,926,608.29 in the previous year, indicating increased investment activity[30]. Equity - The company’s total equity attributable to shareholders increased by 9.91% to ¥2,901,900,767.26 compared to the end of the previous year[3]. - The company's equity attributable to shareholders of the listed company was CNY 29.02 billion, up 9.91% from the end of the previous year[13]. - Total equity reached CNY 2,817,927,637.64, with equity attributable to shareholders of the parent company at CNY 2,640,159,069.96[35]. - The company reported an unallocated profit of CNY 837,293,855.00 within its equity structure[35]. Investments and Acquisitions - Fixed assets increased by 135.51% to ¥265,250,401.29, primarily due to the acquisition of Fujian Kaili Biological Products Co., Ltd.[8]. - The company acquired an 85.1166% stake in Fujian Kaili, a high-tech enterprise engaged in the R&D, production, and sales of biopesticide raw materials and formulations, which holds a patent for Zhongshengmycin raw materials[15]. - The company plans to integrate and acquire in the ecological agriculture sector, focusing on product research and application technology innovation[14]. - The company aims to enhance its oil and fat industry chain by establishing long-term partnerships with local enterprises through overseas asset acquisitions and joint ventures, focusing on stable and traceable oil material supply[16]. Strategic Initiatives - The company aims to combine trade with high technology, striving to become a large integrated enterprise in trade and industry[14]. - The company has established strategic partnerships with several Fortune 500 companies, maintaining a leading position in the bulk commodity trading sector[14]. - The company emphasizes the innovation and product layout in biopesticide research and development, collaborating with the Chinese Academy of Agricultural Sciences to establish an ecological agriculture R&D center[15]. Other Information - The company’s subsidiary, Yuanda Oil (Dongguan) Co., Ltd., was approved to become a designated delivery warehouse for palm oil at the Dalian Commodity Exchange[16]. - The company received approval from the China Securities Regulatory Commission for a non-public issuance of A-shares, indicating ongoing capital-raising efforts[17]. - The report for the third quarter of 2021 was not audited[36].

Financial Performance - The company's operating revenue for the reporting period reached ¥39.91 billion, representing a 70.73% increase compared to ¥23.38 billion in the same period last year[19]. - Net profit attributable to shareholders was ¥132.09 million, a significant turnaround from a loss of ¥99.06 million in the previous year, marking a 233.34% increase[19]. - The net profit after deducting non-recurring gains and losses was ¥131.20 million, compared to a loss of ¥35.99 million last year, reflecting a 464.58% improvement[19]. - The net cash flow from operating activities was ¥471.23 million, a 451.23% increase from a negative cash flow of ¥134.17 million in the same period last year[19]. - Basic earnings per share increased to ¥0.25 from a loss of ¥0.18, representing a 238.89% improvement[19]. - Total assets at the end of the reporting period were ¥8.60 billion, up 29.98% from ¥6.61 billion at the end of the previous year[19]. - Net assets attributable to shareholders increased to ¥2.78 billion, a 5.14% rise from ¥2.64 billion at the end of the previous year[19]. Business Strategy and Operations - The company plans to focus on high-tech agricultural development while expanding its commodity trading business, aiming to integrate trade with industry and high technology[27]. - The company operates in three main sectors: trade, ecological agriculture, and oil, with over 30 subsidiaries and business institutions established in multiple countries[27]. - The company maintained a leading position in the bulk commodity trade sector, establishing strategic partnerships with multiple Fortune 500 companies[29]. - The export scale of foreign trade business increased year-on-year, with stable profit margins despite challenges such as international shipping difficulties and exchange rate fluctuations[29]. - The company established a research and development center in collaboration with the Chinese Academy of Agricultural Sciences to innovate in biopesticide development[30]. - The company acquired an 85.12% stake in Fujian Kaili Biological Products Co., which specializes in biopesticide research and production[30]. - The company is conducting due diligence for a proposed acquisition of 100% of Liaoning Weike Biological Engineering Co., which focuses on biopesticides and biofertilizers[30]. - The company aims to enhance its oilseed supply chain through overseas asset acquisitions and joint ventures, improving resource quality and traceability[31]. Revenue and Sales - Revenue from commodity trading was ¥39,889,528,812.52, accounting for 99.94% of total revenue, with a year-on-year growth of 70.92%[36]. - Domestic sales amounted to ¥33,947,647,582.44, making up 85.05% of total revenue, reflecting a 70.22% increase from the previous year[36]. - Revenue from liquefied products trading was ¥19,349,234,320.84, which is 48.48% of total revenue, showing a 71.27% increase year-on-year[36]. - Metal products trading revenue surged to ¥9,897,670,245.33, a remarkable increase of 148.20% compared to the previous year[36]. - The gross profit margin for commodity trading improved by 0.48% year-on-year, reaching 1.62%[37]. Cash Flow and Investments - Cash flow from operating activities increased by 451.23% to CNY 471.23 million, primarily due to increased sales revenue[34]. - The company's cash and cash equivalents increased to ¥3,415,439,835.53, representing 39.73% of total assets, up from 27.49% the previous year[42]. - The company reported a total of ¥1,325,332,541.66 in receivables financing during the reporting period[47]. - The company has made significant equity investments, including a 85.12% stake in Fujian Kaili Biological Products Co., Ltd. for ¥478,940,000.00[50]. - The total amount of derivative investments was ¥783,519,000.34, with a net investment amount of ¥829,711,000.00 at the end of the reporting period[55]. Risk Management - The company faces macroeconomic volatility risks, with recent uncertainties impacting commodity prices and operational pressures[65]. - The market risk associated with hedging strategies may lead to significant losses if market conditions change drastically, highlighting the importance of effective risk management[66]. - The company has established risk control teams to monitor both spot and futures markets, ensuring effective execution of its hedging strategies[66]. - Cash liquidity risks may arise from margin requirements in futures trading, potentially leading to forced liquidation if cash reserves are insufficient[66]. - The company has implemented measures to mitigate contract performance risks by conducting thorough credit assessments of suppliers and customers[67]. Shareholder and Equity Management - The company does not plan to distribute cash dividends or issue bonus shares for the reporting period[6]. - The company has not sold any significant assets or equity during the reporting period, indicating stability in its asset management[58][59]. - The company reported a total cash dividend of approximately CNY 18.21 million distributed prior to the cancellation of 55,759,636 shares[95]. - The second compensation plan involves the repurchase and cancellation of 33,934,438 shares, with a total cash dividend of CNY 11.08 million to be returned[96]. - The largest shareholder, China Yuanda Group Co., Ltd., holds 41.17% of the total shares, amounting to 209,522,100 shares[123]. Environmental and Social Responsibility - The company has a wastewater treatment capacity of 360 tons per day and operates normally[76]. - The company has a deodorization tower with a capacity of 1200 tons per day, also operating normally[76]. - The total wastewater discharge is 0.21557 tons, while the approved discharge limit is 3.237 tons per year, indicating no exceedance[76]. - The company received no administrative penalties for environmental issues during the reporting period[77]. - The company continues to promote the "Yuan Da Anxin Village" social welfare project, donating educational materials to schools[79]. Financial Reporting and Compliance - The financial report for the half-year period was not audited[86]. - The company’s financial statements were approved by the board of directors on August 9, 2021, ensuring compliance with accounting standards[173]. - The company adheres to the enterprise accounting standards, ensuring that financial statements accurately reflect its financial position, operating results, and cash flows[176]. - The accounting period is defined as January 1 to December 31 each year[177]. Future Outlook - The company has plans to focus on new product development and market expansion to drive future revenue growth[164]. - The overall financial health of the company suggests potential opportunities for mergers and acquisitions to strengthen market position[164].

Financial Performance - The company's operating revenue for Q1 2021 was ¥17,870,174,057.49, representing an increase of 81.80% compared to the same period last year[8]. - The net profit attributable to shareholders was ¥59,136,325.01, a significant turnaround from a loss of ¥163,659,414.65 in the previous year, marking a 136.13% improvement[8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥103,662,253.19, compared to a loss of ¥110,663,626.09 last year, reflecting a 193.67% increase[8]. - The basic earnings per share increased to ¥0.12 from a loss of ¥0.30, representing a 140.00% improvement[8]. - The company achieved operating revenue of 17.87 billion yuan, representing a year-on-year growth of 81.80%[33]. - The net profit attributable to shareholders was 59.14 million yuan, an increase of 136.13% year-on-year[33]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 103.66 million yuan, up 193.67% year-on-year[33]. - The company reported a total comprehensive income for Q1 2021 of ¥85,701,522.39, compared to a loss of ¥121,448,376.34 in the previous year[51]. Assets and Liabilities - The total assets at the end of the reporting period were ¥8,108,169,351.87, up 22.59% from the end of the previous year[8]. - The net assets attributable to shareholders increased to ¥2,710,380,114.05, a rise of 2.66% compared to the previous year[8]. - Total liabilities reached ¥5,193,492,612.45, compared to ¥3,796,158,878.80, indicating an increase of around 37%[42]. - The company's total assets amounted to ¥8,108,169,351.87, up from ¥6,614,086,516.44, which is an increase of about 22.5%[43]. - Short-term borrowings surged to ¥952,415,296.48 from ¥327,130,623.79, representing an increase of approximately 191.5%[41]. - The company's total liabilities increased significantly, with accounts payable rising by 36.79% to ¥1,857,796,262.45 due to increased procurement volumes[16]. Cash Flow - The net cash flow from operating activities was negative at -¥217,869,955.55, worsening by 102.32% compared to -¥107,685,253.38 in the same period last year[8]. - The company reported a net cash outflow from operating activities of ¥-217,869,955.55, which is a 102.32% increase in outflow compared to the previous year[17]. - Cash inflows from operating activities amounted to CNY 19.97 billion, up from CNY 11.47 billion in the previous period, representing a growth of approximately 74%[57]. - The net cash flow from investing activities was positive CNY 122.80 million, down from CNY 293.41 million in the previous year[58]. - The net cash flow from financing activities was CNY 527.87 million, compared to CNY 289.19 million in the same period last year, reflecting a growth of approximately 83%[59]. Investments and Subsidiaries - The company signed agreements to acquire 85.12% of Fujian Kaili Biological Products Co., Ltd. and 100% of Liaoning Weike Biological Engineering Co., Ltd.[34]. - The company completed the first phase of performance compensation related to a major asset restructuring, involving the repurchase of 55,759,636 shares[18]. - The second phase of performance compensation was approved, involving the repurchase of 33,934,438 shares, following a judicial ruling on a related case[19]. - The bankruptcy proceedings for the subsidiary, Far East Petrochemical Co., Ltd., are ongoing after it filed for bankruptcy in November 2020[20]. - The company’s subsidiary, Yuanda Petrochemical Co., Ltd., applied for bankruptcy liquidation, indicating potential financial distress within the group[22]. Risk Management - The company has established strict risk management measures for derivative investments, including a stop-loss mechanism to limit losses beyond a certain threshold[26]. - The company’s derivative trading activities are subject to market risks, liquidity risks, credit risks, operational risks, policy risks, and legal risks[26]. - The company’s risk control measures include selecting reputable futures brokerage firms and establishing a comprehensive management process for derivative investments[26]. Research and Development - The company plans to invest 10 million yuan to establish a research and development center in collaboration with the Chinese Academy of Agricultural Sciences[34]. - The first phase of the R&D center will have an incubation fund of 50 million yuan provided by the company or its affiliated agricultural high-tech enterprises[36]. - The company emphasizes innovation in biological pesticide research and development, leveraging partnerships with leading research institutions[36]. - The company aims to continue increasing investments in the agricultural high-tech sector to drive innovation and industrialization[36].

Financial Performance - The company's operating revenue for 2020 was CNY 59,041,455,357.74, a decrease of 12.86% compared to CNY 67,754,168,435.70 in 2019[17] - The net profit attributable to shareholders was a loss of CNY 113,193,841.51, representing a decline of 166.92% from a profit of CNY 169,154,970.30 in the previous year[17] - The net cash flow from operating activities was negative CNY 340,301,495.45, a decrease of 198.75% compared to positive CNY 344,596,357.08 in 2019[17] - The basic earnings per share for 2020 was -CNY 0.21, down 167.74% from CNY 0.31 in 2019[17] - Total assets at the end of 2020 were CNY 6,614,086,516.44, a decrease of 3.49% from CNY 6,853,027,863.56 at the end of 2019[17] - The net assets attributable to shareholders decreased by 5.20% to CNY 2,640,159,069.96 from CNY 2,784,967,999.37 in 2019[17] - The company reported a significant increase of 68.71% in net profit attributable to shareholders after deducting non-recurring gains and losses, amounting to CNY 46,212,410.38 compared to CNY 27,392,171.89 in 2019[17] - The weighted average return on net assets was -4.17%, a decrease of 10.42% from 6.25% in the previous year[17] - The company reported a significant loss in investment income of -¥188,818,916.69, primarily due to losses from derivative investments[59] - The company reported a total revenue of 750,713,050.54 CNY for the year 2020, reflecting a significant adjustment due to the implementation of the new revenue recognition standards[105] Revenue Breakdown - Domestic sales accounted for 86.47% of total revenue, amounting to CNY 51.06 billion, while foreign sales were 13.53%, totaling CNY 7.99 billion, reflecting a decrease of 27.19%[44] - The company’s core business, commodity trading, generated CNY 58.94 billion, representing 99.82% of total revenue, down 12.91% from the previous year[44] - The company’s logistics agency services saw a revenue increase of 35.35%, reaching CNY 100.85 million[44] Operational Challenges - The global economic downturn and the COVID-19 pandemic significantly impacted commodity market demand, leading to increased price volatility[29] - The company faced challenges due to the COVID-19 pandemic and trade tensions, leading to initial losses in Q1 2020, but profitability was restored in subsequent quarters[38] - The company reported a loss of non-current asset disposal of approximately -12.15 million, compared to a gain of 2.01 million in 2019[24] Risk Management - The company has implemented effective risk management measures to monitor and control financial and operational risks across its subsidiaries[32] - The company has established risk control teams to monitor and manage risks associated with its spot and futures trading operations[92] - The company is addressing contract performance risks by conducting thorough credit assessments of suppliers and customers to mitigate potential defaults[92] - The company has implemented strategies to manage foreign exchange risks due to significant fluctuations in exchange rates, impacting import costs and export revenues[93] Investments and Acquisitions - The company plans to invest in the bio-pesticide and edible oil sectors, with a focus on high-tech industries closely related to national policies and public welfare[85] - The company has signed a framework agreement to acquire 85.1167% of Fujian Kaili Biotechnology Co., Ltd., with an investment of 1 million yuan to establish a research and development center with the Chinese Academy of Agricultural Sciences[87] - The company plans to improve its upstream supply chain by acquiring overseas assets and establishing joint ventures to secure stable and high-quality oilseed resources[88] Social Responsibility and Environmental Impact - The company actively participated in social responsibility initiatives, donating approximately 2 million RMB worth of medical supplies during the COVID-19 pandemic[140] - The "Yuan Da Anxin Village" social welfare project continued, providing educational materials and winter clothing to children in need[141] - The company is classified as a key pollutant discharge unit and has implemented pollution control facilities with a wastewater treatment capacity of 360 tons per day[143] - The company has received environmental impact assessment approval and holds a pollution discharge permit valid until August 5, 2023[145] Corporate Governance - The company has maintained a stable management team with no significant changes in the board of directors during the reporting period[172] - The company emphasizes compliance and governance, with no recent penalties reported for its directors and senior management[178] - The independent board members confirmed that the internal control evaluation report for 2019 comprehensively and objectively reflects the company's internal control system, operations, and compliance[194] Shareholder Information - The total number of shares is 542,874,902, with 14.54% being limited shares and 85.46% being unrestricted shares[155] - The largest shareholder, China Yuanda Group, holds 38.59% of the shares, totaling 209,522,100 shares, with 76,900,000 shares pledged[158] - The company has not conducted any share buybacks or repurchases during the reporting period[156] Employee and Management - The company employed a total of 623 staff, with 595 from major subsidiaries and 28 from the parent company[181] - The educational background of employees includes 79 with master's degrees or above, 367 with bachelor's degrees, and 108 with associate degrees[181] - The company has a comprehensive employee training program covering new employee orientation, professional skills training, and management training[183]

Financial Performance - Operating revenue decreased by 5.91% to CNY 16,450,096,958.21 for the current period, and by 20.66% to CNY 39,828,721,919.73 year-to-date[7] - Net profit attributable to shareholders increased by 119.75% to CNY 46,811,553.15 for the current period, but decreased by 177.14% to CNY -52,248,872.42 year-to-date[7] - Basic earnings per share rose by 119.90% to CNY 0.0862 for the current period, while year-to-date it was CNY -0.0962, a decrease of 177.58%[7] - Net profit for Q3 2020 reached CNY 62,812,647.34, an increase of 83.8% compared to CNY 34,237,434.37 in Q3 2019[48] - The company reported a total comprehensive income of ¥-6,591,483.22 for the current period, compared to ¥114,384,579.75 in the previous period[57] - The company reported a net loss from trading financial assets and derivatives of CNY -52,526,552.34 during the reporting period[8] Cash Flow - Net cash flow from operating activities was CNY -320,851,232.60, a decrease of 181.85% compared to the same period last year[7] - The net cash flow from operating activities worsened by 136.06% to -¥455,019,204.43, attributed to a decrease in cash received from sales[16] - The net cash flow from investing activities increased by 1027.70% to ¥493,693,001.39, mainly due to higher futures withdrawals[16] - The net cash flow from financing activities improved by 138.79% to ¥129,678,510.36, reflecting an increase in financing scale[16] - Cash inflows from operating activities totaled CNY 45,150,489,944.41, a decrease from CNY 56,642,738,956.96 in the previous year[63] - The net cash flow from financing activities was CNY 129,678,510.36, compared to CNY -334,342,682.56 in the same period last year[64] Assets and Liabilities - Total assets increased by 6.64% to CNY 7,307,974,747.03 compared to the end of the previous year[7] - The company's trading financial assets decreased by 55.37% to ¥305,214,789.95 due to a reduction in the balance of wealth management products[15] - The total liabilities increased to ¥4,485,868,285.81 from ¥3,990,195,951.51, representing a growth of approximately 12.4%[39] - The total equity attributable to the owners of the parent company decreased to ¥2,728,972,470.51 from ¥2,784,967,999.37, a decline of about 2.0%[40] - The total assets as of the end of Q3 2020 amounted to CNY 4,219,852,201.33, slightly down from CNY 4,226,608,481.88 at the end of the previous quarter[44] Shareholder Information - The total number of shareholders at the end of the reporting period was 23,875[11] - The largest shareholder, China Yuanda Group Co., Ltd., held 38.59% of the shares, totaling 209,522,100 shares[11] Investment and Financial Management - Investment income turned negative at -¥129,744,149.23, a decline of 178.84% due to significant losses from derivative positions[15] - The company reported a total of ¥150,257,000 in entrusted financial management, with an outstanding balance of ¥18,328,460[31] - The company has established management systems and rules for its subsidiary's derivative investment business, which is closely related to daily operations and helps expand operational scale[29] Risk Management - The company has implemented strict position limits and stop-loss mechanisms to manage market risk associated with derivative holdings[28] - The liquidity risk management includes monitoring margin levels and ensuring that only liquid contracts are traded[28] - The company has established a comprehensive risk control framework to mitigate operational and technical risks in trading activities[28] Performance Obligations - The company has not fully fulfilled its performance compensation obligations due to the failure of the major asset restructuring target's performance commitments[23] - The first performance compensation has been completed, but the second compensation is pending due to ongoing legal proceedings related to market manipulation allegations[23] - The company will actively urge the involved parties to fulfill all performance compensation obligations according to the implementation plan[23]

Financial Performance - The company's operating revenue for the first half of 2020 was ¥23,378,624,961.52, a decrease of 28.55% compared to ¥32,718,020,949.13 in the same period last year[17]. - The net profit attributable to shareholders of the listed company was -¥99,060,425.57, representing a decline of 313.33% from ¥46,434,495.45 in the previous year[17]. - The company achieved operating revenue of 23.38 billion yuan, a decrease of 28.55% compared to the same period last year[34]. - The net profit attributable to shareholders was -99.06 million yuan, a decline of 313.33% year-on-year[34]. - The company reported a basic earnings per share of -¥0.18, a decrease of 325.00% compared to ¥0.08 in the same period last year[17]. - The total revenue for the reporting period was approximately ¥936.30 million, a decrease of 5.1% compared to the previous period[51]. - The company reported a net loss of approximately ¥50.48 million for the period[51]. - The total profit for the first half of 2020 was a loss of CNY 73,136,284.21, down from a profit of CNY 105,672,481.42 in the previous year[150]. - The total comprehensive income for the first half of 2020 was a loss of CNY 62,937,225.95, compared to a profit of CNY 75,512,857.52 in the first half of 2019[150]. Cash Flow and Assets - The net cash flow from operating activities was -¥134,167,971.83, an improvement of 76.90% compared to -¥580,913,907.20 in the same period last year[17]. - The total assets at the end of the reporting period were ¥7,826,573,277.03, an increase of 14.21% from ¥6,853,027,863.56 at the end of the previous year[17]. - The net increase in cash and cash equivalents was ¥582,385,294.96, a 215.90% improvement from a net decrease of ¥502,508,878.06 in the previous year[39]. - The company's total current assets as of June 30, 2020, amount to ¥7,183,630,942.17, an increase from ¥6,283,184,119.43 at the end of 2019[139]. - The company's cash and cash equivalents decreased to CNY 40,369,816.55 from CNY 151,430,743.78 at the end of 2019, a decline of 73.3%[144]. - The total liabilities as of June 30, 2020, amounted to CNY 5,043,611,997.97, an increase from CNY 3,990,195,951.51 at the end of 2019[142]. Operational Challenges - The global economic trade was severely impacted by the COVID-19 pandemic, leading to a significant shrinkage in demand for bulk commodities[24]. - The company faced significant challenges due to the COVID-19 pandemic, leading to high inventory and sales difficulties[35]. - The company faced significant challenges in Q1 2020 due to the COVID-19 pandemic and the Saudi-Russian oil price war, leading to operational losses[69]. - The company adjusted its operational strategy in the second quarter to partially offset losses from the first quarter[34]. Investment and Financing Activities - Investment activities generated a net cash inflow of ¥491,863,216.51, representing a 336.31% increase from ¥112,732,327.94 year-on-year[39]. - The financing activities resulted in a net cash inflow of ¥225,781,346.00, a substantial increase of 693.72% compared to a net outflow of ¥38,027,987.26 in the previous year[39]. - The company reported a financial expense of CNY 30,273,111.20 for the first half of 2020, compared to CNY 22,185,818.03 in the same period last year, an increase of 36.4%[147]. Shareholder and Equity Information - The company does not plan to distribute cash dividends or issue bonus shares for the reporting period[6]. - The total equity attributable to shareholders was CNY 2,684,846,884.49, down from CNY 2,784,967,999.37 at the end of 2019, reflecting a decrease of 3.6%[142]. - The company has not implemented any stock incentive plans or employee shareholding plans during the reporting period[92]. - The total number of shares is 542,874,902, with 14.54% being limited shares[119]. Risk Management and Compliance - The company has implemented strict risk control measures for derivative investments, including market, liquidity, credit, operational, and legal risks[60]. - The company has established management systems and rules for its derivative investment business, ensuring compliance with relevant laws and regulations[61]. - The company has committed to enhancing its internal control systems and complying with relevant laws and regulations to mitigate future risks[86]. Environmental and Social Responsibility - The company donated over 2 million yuan worth of medical supplies to support COVID-19 prevention efforts[35]. - The wastewater treatment plant has a processing capacity of 360 tons per day and is operating normally[111]. - The company holds a pollution discharge permit valid from September 26, 2018, to July 5, 2020[112]. - The company has established an emergency response plan for environmental incidents, detailing various aspects of risk management[112]. Legal and Regulatory Matters - The company received a qualified audit opinion from Tianheng Accounting Firm for the 2019 financial report due to uncertainties related to a legal case involving its subsidiary, Yuanda Petrochemical, which had 560 million yuan seized[84]. - The impact of the legal case on the company's financial statements for the reporting period remains undetermined, as the case is still under review[85]. - The company’s wholly-owned subsidiary is involved in a legal case regarding market manipulation, with a seized amount of 560 million yuan accounted for as an estimated loss[115].

Financial Performance - The company's operating revenue for Q1 2020 was ¥9,829,692,773.14, a decrease of 36.68% compared to ¥15,522,813,886.39 in the same period last year[7] - The net profit attributable to shareholders was -¥163,659,414.65, representing a decline of 757.63% from ¥24,886,277.39 in the previous year[7] - Basic and diluted earnings per share were both -¥0.30, a decrease of 700.00% from ¥0.05 in the previous year[7] - The company reported a net loss attributable to shareholders of ¥163,659,414.65, a decline of 757.63% compared to a profit of ¥24,886,277.39 in the same period last year, largely due to the adverse effects of the pandemic on market supply and prices[15] - The net profit for Q1 2020 was a loss of ¥120,582,016.65, compared to a profit of ¥25,024,576.39 in Q1 2019, representing a significant decline[47] - The total comprehensive income for the first quarter was -660,020.30 yuan, compared to -514,133.72 yuan in the previous year, reflecting a decline of approximately 28.4%[52] Cash Flow - The net cash flow from operating activities improved to -¥107,685,253.38, a 57.79% increase compared to -¥255,129,650.95 in the same period last year[7] - The net cash flow from operating activities improved by 57.79%, reaching -¥107,685,253.38 compared to -¥255,129,650.95 in the previous year, mainly due to reduced procurement expenditures[16] - The net cash flow from investing activities was ¥293,411,583.34, a significant increase of 199.53% from -¥294,782,617.68, driven by increased futures withdrawals[16] - The net cash flow from financing activities increased by 8178.33% to ¥289,191,714.60, due to larger financing scale and reduced loan repayments[16] - The net cash flow from investment activities was -14,931.75 million, indicating a significant outflow compared to the previous period[59] Assets and Liabilities - Total assets at the end of the reporting period were ¥7,739,153,584.20, an increase of 12.93% from ¥6,853,027,863.56 at the end of the previous year[7] - The company's total assets amounted to ¥4,224,644,455.29, slightly down from ¥4,226,608,481.88 at the end of the previous period[43] - Total current liabilities rose to CNY 4,412,141,679.28, up from CNY 3,375,192,942.10, indicating an increase of approximately 30.7%[38] - The company's total liabilities reached CNY 4,997,770,048.49, compared to CNY 3,990,195,951.51, marking a rise of around 25.3%[38] - The equity attributable to the owners of the parent company decreased to CNY 2,619,722,504.01 from CNY 2,784,967,999.37, a decline of about 5.9%[39] Investment and Financial Management - The company received government subsidies amounting to ¥10,196,561.14 related to industrial transformation and upgrading[8] - The company reported a fair value change gain of ¥64,211,053.52 from trading financial assets and derivatives during the reporting period[8] - The company has engaged in wealth management with a total investment of 128,700,000 CNY in bank financial products, with an outstanding balance of 61,000,000 CNY[25] - The company has not engaged in any securities investments during the reporting period, maintaining a focus on core operations[23] - The company has not encountered any situations where expected recoveries of principal are at risk, indicating effective risk management[25] Derivative Investments - The company's derivative investment fair value change loss for the reporting period was 48,044,005.55 yuan, indicating a significant impact on financial performance[28] - The company has implemented strict risk control measures for derivative investments, including position limits and stop-loss mechanisms to mitigate market risk[27] - The company plans to continue its derivative investment business in 2020, which is closely related to its operational needs and aims to expand its business scale[28] - The independent directors have expressed support for the company's derivative investment activities, affirming compliance with regulations and protection of shareholder interests[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,246[11] - A total of 33,184,787 shares were to be pledged for the second compensation, with 28,628,781 shares already pledged, leaving 4,556,006 shares pending due to legal restrictions on an individual[22] - The company has committed to performance compensation obligations, with the first compensation completed as of August 16, 2018, and the second compensation pending due to ongoing legal proceedings[21] Operational Metrics - Operating costs decreased by 36.34% to ¥9,746,232,250.90 from ¥15,309,308,071.67, reflecting the decline in revenue[15] - Financial expenses increased by 292.57% to ¥20,569,426.52, mainly due to exchange rate fluctuations leading to increased foreign exchange losses[15] - The company reported a decrease in cash received from sales of goods and services, which was 11,348,808,979.97 yuan, down from 17,670,640,370.34 yuan, a decline of about 35.5%[54]